|
Volumn 98, Issue 17, 2001, Pages 9808-9813
|
Treatment of spinal muscular atrophy by sodium butyrate
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUTYRIC ACID;
CELL PROTEIN;
SURVIVAL MOTOR NEURON PROTEIN;
UNCLASSIFIED DRUG;
ALTERNATIVE RNA SPLICING;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTERIOR HORN CELL;
ARTICLE;
AUTOSOMAL RECESSIVE DISORDER;
CONTROLLED STUDY;
HISTOPATHOLOGY;
LYMPHOID CELL;
MOTONEURON;
MOUSE;
NONHUMAN;
PARALYSIS;
PREGNANCY;
PRIORITY JOURNAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SPINAL MUSCULAR ATROPHY;
TRANSGENIC MOUSE;
WESTERN BLOTTING;
ABNORMALITIES, MULTIPLE;
ALTERNATIVE SPLICING;
ANIMALS;
BUTYRATES;
CELL LINE, TRANSFORMED;
CROSSES, GENETIC;
CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN;
DRUG EVALUATION, PRECLINICAL;
ENHANCER ELEMENTS (GENETICS);
ENZYME INHIBITORS;
EXONS;
FEMALE;
FETAL DISEASES;
FLAVONOIDS;
GESTATIONAL AGE;
HAIR;
HUMANS;
LYMPHOCYTES;
MAP KINASE SIGNALING SYSTEM;
MATERNAL-FETAL EXCHANGE;
MICE;
MICE, KNOCKOUT;
MICE, TRANSGENIC;
MUSCULAR ATROPHY, SPINAL;
NERVE TISSUE PROTEINS;
OKADAIC ACID;
PHENOTYPE;
PHOSPHOPROTEIN PHOSPHATASE;
PREGNANCY;
RNA, MESSENGER;
RNA-BINDING PROTEINS;
TAIL;
ANIMALIA;
MUS MUSCULUS;
|
EID: 0035859952
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.171105098 Document Type: Article |
Times cited : (359)
|
References (38)
|